Successful treatment of human immunodeficiency virus-associated highly active antiretroviral therapy-resistant vacuolar myelopathy with intravenous immunoglobulin

Successful treatment of human immunodeficiency virus-associated highly active antiretroviral therapy-resistant vacuolar myelopathy with intravenous immunoglobulin

For the first time, human immunodeficiency virus (HIV)-associated vacuolar myelopathy (VM) was detailed in an autopsy-based study of 89 cases in 1985. This condition is the most common cause for spinal cord lesions in HIV patients. VM's pathogenic mechanism remains unclear; however, it is assum...

Full description

Bibliographic Details
Main Authors: Lidiia N Prakhova, Aleksandr G Ilves, Svetlana N Kizhlo, Zhanna I Savintseva
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Annals of Indian Academy of Neurology
Subjects:
human immunodeficiency virus-associated lesions of the nervous system
human immunodeficiency virus-associated myelopathy
intravenous immunoglobulin administration
Online Access:http://www.annalsofian.org/article.asp?issn=0972-2327;year=2020;volume=23;issue=2;spage=220;epage=222;aulast=

Internet

http://www.annalsofian.org/article.asp?issn=0972-2327;year=2020;volume=23;issue=2;spage=220;epage=222;aulast=

Similar Items